NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Development of Non-Invasive Brain Stimulation Techniques

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts




Sponsoring Institute

National Institute of Mental Health (NIMH)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 18 Years
Max Age: 65 Years

Referral Letter Required


Population Exclusion(s)

Adults who are or may become unable to consent;
Pregnant Women;
Non-English Speaking;


Non-Invasive Brain Stimulation;
TMS-Evoked Potential;
Transcranial Magnetic Stimulation (TMS);

Recruitment Keyword(s)



Normal Physiology

Investigational Drug(s)


Investigational Device(s)



Device: Sham TMS
Device: TMS

Supporting Site

National Institute of Mental Health


Noninvasive brain stimulation (NIBS) may help diagnose and treat psychiatric and neurological illness. But there is not enough research on how to apply NIBS. This includes how strong to make it, where on the brain to apply it, and for how long. Researchers also want to see what the brain is doing when it receives NIBS.


To increase the effectiveness of NIBS.


Healthy native English speakers ages 18-65


Participants will be screened under another protocol with:

Medical and psychiatric history

Psychiatric evaluation

Physical exam

Urine tests

All participants will start with a 2-hour visit for screening. (see below). They may learn how to do tasks that will be used later. After the screening session, they will be scheduled for an MRI session.

The next part of the study is 4 substudies. Each substudy includes up to 4 sessions. A session is usually 2-3 hours but can last up to 8 hours. Participants can join multiple substudies, but only 1 at a time. They can do only 1 session on a given day.

Each substudy includes the following:

Behavioral tests: Interviews; questionnaires; simple tasks; and tests of memory, attention, and thinking

Electromyography: Small sticky electrodes on the skin measure muscle activity.

Transcranial magnetic stimulation: A wire coil is held to the scalp. A brief electrical current passes through the coil and affects brain activity.

Magnetic resonance imaging (MRI): Participants lie on a table that slides into a machine that takes pictures of the brain. A coil is placed over the head. They will perform simple tasks while in the scanner. They may also get TMS.

Electroencephalography: Small electrodes on the scalp record brain waves.

Sponsoring Institution: National Institute of M

--Back to Top--


INCLUSION CRITERIA (for all substudies):

-Male and female subjects between 18 and 65 years of age.

-Subjects must be able to give written informed consent prior to participation in this study.

-All subjects must have undergone a screening assessment under protocol 01-M-0254, The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers or under protocol 17-M-0181 (Recruitment and Characterization of Research Volunteers for NIMH Intramural Studies).

-For cognitive experiments utilizing language stimuli only native English speakers will be enrolled.

EXCLUSION CRITERIA (for all substudies):

-Women who are pregnant or breastfeeding.

-History of any Axis I DSM-5 disorder, except alcohol abuse outside of one year.

-History of seizure (childhood febrile seizures are acceptable and these subjects may be included in the study), history of epilepsy in self or first degree relatives, stroke, brain surgery, known structural brain lesion, or with history of any head trauma within 6 months of screening, or, beyond 6 months prior to screening, history of head trauma with evidence of traumatic abnormality appearing on their brain scan, or with loss of consciousness >5 min, or with other sequelae, excluding headache, lasting >24 hours.

-Increased risk of seizure for any reason, including prior diagnosis of increased intracranial pressure (such as after large infarctions or trauma), or currently taking medication that lowers the seizure threshold. Excluded medications and substances include: imipramine, amitriptyline, doxepine, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines, cocaine, (MDMA, ecstasy), phencyclidine (PCP, angel s dust), ketamine, gamma-hydroxybutyrate (GHB), alcohol, theophylline.

-A history of drug or alcohol abuse within 1 year or a lifetime history of drug or alcohol dependence (DSM-5 criteria).

-Presence of ferromagnetic metal in the body, for example metallic (ferromagnetic) implants (e.g, heart pacemaker, aneurysm clip).

-Subjects with an unstable or serious medical or neurological disorder.

-No concurrent medications, such as psychotropic drugs, that affect brain function.

-Presence of any medical illness likely to alter brain morphology and/or physiology (e.g., hypertension, diabetes) even if controlled by medications.

-Positive test for HIV.

-Subjects who have hearing loss that has been clinically evaluated and diagnosed.

-Participants who are uncomfortable in small closed spaces (have claustrophobia), unable to lie comfortably supine for up to 60 minutes, and would feel uncomfortable in the MRI machine (for subjects doing imaging component of the study only).

-A current NIMH employee or staff or their immediate family member.

-Participant is concurrently participating in another substudy in this protocol, or in any

other study involving NIBS.

--Back to Top--


Not Provided

--Back to Top--


Principal Investigator

Referral Contact

For more information:

Sarah H. Lisanby, M.D.
National Institute of Mental Health (NIMH)
(301) 339-4831

Eva J. Wiener
National Institute of Mental Health (NIMH)
National Institutes of Health
Building 10
Room 2D39
10 Center Drive
Bethesda, Maryland 20892
(312) 222-3551

Office of Patient Recruitment
National Institutes of Health Clinical Center (CC)
Building 61, 10 Cloister Court
Bethesda, Maryland 20892
Toll Free: 1-800-411-1222
Local Phone: 301-451-4383
TTY: TTY Users Dial 7-1-1

Clinical Trials Number:


--Back to Top--